Novo Nordisk A S NVO Earnings Call Transcripts

NYSE NVO
$39.15 +0.86 (+2.25%)
At close: Oct 29, 2026 · 4:00 PM EDT
21 earnings calls on file for Novo Nordisk A S, from Q1 2020 to Q3 2025. Each transcript opens in a new tab.
Latest earnings call

Novo Nordisk A S Q3 2025 Earnings Call

Nov 5, 2025 9,581 words · 42 min read
  • Maziar DoustdarPresident & Chief Executive Officer
  • Ludovic HelfgottExecutive Vice President, North America Operations
  • David MooreExecutive Vice President, U.S. Operations
  • Martin Holst LangeExecutive Vice President, Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Novo Nordisk A S Earnings Call Transcripts

Calls21
LatestNov 5, 2025
SinceQ1 2020

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 21 Novo Nordisk A S transcripts Register to get access to Novo Nordisk A S’s earnings call transcripts.